✦ LIBER ✦

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas

✍ Scribed by Annick Desjardins; Jennifer A. Quinn; James J. Vredenburgh; Sith Sathornsumetee; Allan H. Friedman; James E. Herndon; Roger E. McLendon; James M. Provenzale; Jeremy N. Rich; John H. Sampson; Sridharan Gururangan; Jeannette M. Dowell; August Salvado; Henry S. Friedman; David A. Reardon

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 162 KB
Volume: 83
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-006-9302-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of sunitinib and irinoteca

Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma

✍ David A. Reardon; James J. Vredenburgh; April Coan; Annick Desjardins; Katherine 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 197 KB

Phase I pharmacokinetic study of the vas

Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma

✍ David A. Reardon; Merrill J. Egorin; Annick Desjardins; James J. Vredenburgh; Ja 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 1 views

Combination Chemotherapy Using Carboplat

Combination Chemotherapy Using Carboplatin (JM-8) and Etoposide (JET Therapy) for Recurrent Malignant Gliomas: A Phase II Study

✍ K. Watanabe; H. Kanaya; Y. Fujiyama; P. Kim 📂 Article 📅 2002 🏛 Springer Vienna 🌐 English ⚖ 78 KB

A phase I/II trial and pharmacokinetic s

A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 187 KB

Treatment of recurrent malignant suprate

Treatment of recurrent malignant supratentorial gliomas with the association of procarbazine, thiotepa and vincristine: A phase II study

✍ A. Ameri; M. Poisson; Q. M. Chen; J. Y. Delattre 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 368 KB

Multi-institutional phase II study of te

Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas

✍ Casilda Balmaceda; David Peereboom; Susan Pannullo; Ying Kuen K. Cheung; Paul G. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract ## BACKGROUND. The prognosis for patients with recurrent high‐grade gliomas is poor and treatment options are limited. Current chemotherapeutic regimens can improve clinical outcomes, but extend survival by only a few months. Temozolomide is a methylating agent that is typically admini